Q1 2025 · 13F-HR
Nan Fung Group Holdings Ltdholdings as filed
Filed 2025-05-14 · accession 0001012975-25-000235
$122.6M
Reported value
35
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $12.2M | 9.98% | 368,665 | Common | SOLE |
| H5870P102 | OCS | OCULIS HOLDING AG | $9.8M | 7.99% | 514,702 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $9.5M | 7.71% | 119,196 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $9.4M | 7.66% | 147,990 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $9.2M | 7.48% | 253,675 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $6.6M | 5.39% | 146,765 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $5.9M | 4.79% | 121,400 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $5.7M | 4.64% | 79,650 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $5.3M | 4.34% | 158,605 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $5.1M | 4.12% | 120,038 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $4.3M | 3.49% | 15,722 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $4.0M | 3.29% | 414,246 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $3.9M | 3.21% | 11,872 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $3.6M | 2.91% | 59,022 | Common | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $3.5M | 2.87% | 664,610 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $3.5M | 2.82% | 227,090 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $2.6M | 2.12% | 49,120 | Common | SOLE |
| 30161Q104 | EXEL | EXELIXIS INC | $2.4M | 1.93% | 64,200 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $2.2M | 1.78% | 1,373,550 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $2.1M | 1.73% | 13,600 | Common | SOLE |
| 34385P108 | LAB | STANDARD BIOTOOLS INC | $2.0M | 1.66% | 1,883,179 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $1.8M | 1.45% | 154,522 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $1.7M | 1.40% | 102,984 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $1.7M | 1.35% | 2,800 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $845,049 | 0.69% | 30,875 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $680,786 | 0.56% | 19,253 | Common | SOLE |
| 753018100 | RANI | RANI THERAPEUTICS HLDGS INC | $621,916 | 0.51% | 493,584 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $585,326 | 0.48% | 68,943 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $565,658 | 0.46% | 463,654 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $466,781 | 0.38% | 1,166,952 | Common | SOLE |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $443,701 | 0.36% | 49,082 | Common | SOLE |
| 23306J309 | DBVT | DBV TECHNOLOGIES S A | $252,988 | 0.21% | 37,095 | Common | SOLE |
| 09769B107 | — | BOLT PROJS HLDGS INC | $249,513 | 0.20% | 811,952 | Common | SOLE |
| N01045207 | AFMDQ | AFFIMED N V | $26,937 | 0.02% | 37,247 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $26,135 | 0.02% | 41,950 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.